Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Outcomes following limited-volume proton therapy for multifocal spinal myxopapillary ependymoma

10/11/2020
/ Publications
/
Toxicity

A study by the Jacksonville group reported the disease control and toxicity in 12 pediatric patients with multifocal spinal myxopapillary ependymoma (MPE)...

Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase trial.

01/10/2020
/ Publications
/
Toxicity

This randomized study compared PBT and radiofrequency ablation (RFA) for patients with recurrent/residual HCC. The local progression free survival values of PBT...

Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma (B/P-RMS).

07/08/2019
/ Publications
/
Toxicity

This study reported outcomes of 19 patients of B/P-RMS treated with PBT. With a median follow-up of 66.2 months, 5-year overall survival (OS) and progression...

Comparative toxicity outcomes of PBT vs IMRT for prostate cancer in the postoperative setting.

07/09/2019
/ Publications
/
Toxicity

A case-matched cohort analysis study compared acute and late genitourinary (GU) and gastrointestinal (GI) toxicity outcomes in patients with prostate cancer (PC...

PBT outcomes for localized unresectable hepatocellular carcinoma.

03/01/2019
/ Publications
/
Survival
Toxicity

A MD Anderson study published in the Green Journal reported outcomes of forty-six patients with HCC, Child-Pugh class of A or B, no prior radiotherapy treated...

Toxicity and Survival After IMPT Versus Passive Scattering PT for NSCLC.

10/10/2020
/ Publications
/
Toxicity
IMPT

This MD Anderson study compared toxicity profiles and clinical outcomes after IMPT versus PSPT for 139 patients with locally advanced NSCLC. Compared to the...

Analysis of Gastrointestinal Toxicity in Patients Receiving PBT for Prostate Cancer

08/08/2018
/ Publications
/
Toxicity

A study by the Seattle group. 192 prostate cancer patients were treated with PBT. With the median follow-up of 1.7 years, most of the observed GI toxicity (>90%...

Clinical outcomes of image-guided PT for histologically confirmed stage I NSCLC.

08/10/2018
/ Publications
/
Toxicity

The interim results of two trials by the researchers in Nagoya, Japan, which aims to assess the efficacy and safety of image-guided proton therapy (IGPT) for...

Initial report of the genitourinary and gastrointestinal toxicity of post-prostatectomy proton therapy for prostate cancer patients undergoing adjuvant or salvage radiotherapy.

08/07/2018
/ Publications
/
Toxicity

A retrospective analysis on 100 patients' acute and late genitourinary (GU) and gastrointestinal (GI) toxicities associated with post-prostatectomy proton...

Minimal toxicity after PBT for prostate and pelvic nodal irradiationresults, proton collaborative group REG001-09 trial.

11/10/2017
/ Publications
/
Toxicity

This PCG study evaluated toxicity outcomes for non-metastatic prostate cancer patients who received pelvic radiation therapy.

The study demonstrated PBT...